Indeed, as Spry2 (and other Sprouty and SPRED proteins) is a potential tumor suppressor protein that is downregulated in many different tumor types (20), targeting S-acylation may present a viable approach to enhance Spry2 levels and restore optimal growth factor signaling. The gene discussed is SPRY2; the disease is neoplasm.